Antihypertensive Therapy Reduces Increased Plasma Levels of Adrenomedullin and Brain Natriuretic Peptide Concomitant with Regression of Left Ventricular Hypertrophy in a Patient with Malignant Hypertension.
Toshio Nishikimi(Kyoto University), Teruo Omae(National Cerebral and Cardiovascular Center), Yuhei Kawano(Fukuoka Institute of Technology), Yoshihiko Saito(National Archives and Records Administration), Kenji Kangawa(National Cerebral and Cardiovascular Center), Kazuo Kitamura(University of Miyazaki), Hisayuki Matsuo(National Cerebral and Cardiovascular Center), Kazuhiko Ishikawa(National Cerebral and Cardiovascular Center), Hiroaki Matsuoka(Social Welfare Department), Fumiki Yoshihara(National Cerebral and Cardiovascular Center)
Cited by 18
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307